-
Enhertu wins Korean approval for HER2-low and HER2-ultra-low metastatic breast cancer
20 Jan 2026 08:41 GMT
… HER2-ultra-low metastatic breast cancer.
The newly added … receptor-positive (HR+) metastatic breast cancer. Chemotherapy follows if … -ultra-low expression metastatic breast cancer. Furthermore, Enhertu … and HER2-low metastatic breast cancer patients who had …
-
<![CDATA[EMA Validates T-DXd for First-Line HER2+ Metastatic Breast Cancer]]>
19 Jan 2026 23:33 GMT
… patients with HER2 positive metastatic breast cancer. News release. Daiichi Sankyo … pertuzumab in HER2-positive metastatic breast cancer (DESTINY-Breast09). ClinicalTrials.gov … with HER2+ advanced/metastatic breast cancer: additional analyses of DESTINY …
-
North Fork Breast Health Coalition to host panel Jan. 31
22 Jan 2026 19:23 GMT
… in Riverhead. It also supports metastatic breast cancer research at Stony Brook University …
-
Receptor Discordance and Molecular Subtype Changes in Visceral Metastases of Breast Cancer
22 Jan 2026 16:53 GMT
… treatment selection in metastatic breast cancer.
Although this … plans.
Abbreviations
MBC, Metastatic breast cancer; ER, Estrogen Receptor … between primary and metastatic breast cancer in the large … molecular subtypes on metastatic breast cancer patients: a …
-
Fast Five Quiz: Advanced BC and ESR1 Mutations
22 Jan 2026 16:46 GMT
… advanced and metastatic breast cancer. They are … advanced and metastatic breast cancer.
ESR1 mutations … metastatic breast cancer.
For patients with ER-positive/HER2-negative metastatic breast cancer … ;HER2-negative metastatic breast cancer remains initial …
-
S2 Episode 4: Interstitial Lung Disease and ADCs in Breast Cancer
22 Jan 2026 15:08 GMT
… Growth Factor Receptor 2-Expressing Metastatic Breast Cancer
Updates in Drug-Related Pneumonitis … -Deruxtecan Pneumonitis in Patients With Metastatic Breast Cancer
CPIC (Clinical Pharmacogenetics Implementation Consortium …
-
Study reveals synergistic effect of CDK2 and CDK4/6 combination therapy
22 Jan 2026 14:56 GMT
… , HER2-negative (HR+/HER2−) metastatic breast cancer, but resistance inevitably develops over …
-
11 high-impact drugs to look out for in 2026
22 Jan 2026 14:55 GMT
… , HER2-negative locally advanced or metastatic breast cancer without PIK3CA mutations. The results …
-
Coweta mother raising funds for own funeral passes away
22 Jan 2026 13:13 GMT
… Gawf who has been battling metastatic breast cancer for three years.
Gawf created …
-
Study identifies a powerful strategy to overcome drug resistance in breast cancer
22 Jan 2026 11:43 GMT
… , HER2-negative (HR+/HER2−) metastatic breast cancer, but resistance inevitably develops over …
About
© 1995-2026